missing translation for 'onlineSavingsMsg'
Learn More

SIRT6 Antibody (OTI1G3), DyLight 350, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-74198UV

Product Code. 18177126

  • € 785.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

SIRT6 Monoclonal specifically detects SIRT6 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SIRT6
Monoclonal
DyLight 350
50mM Sodium Borate with 0.05% Sodium Azide
SIRT6
Recombinant protein fragment corresponding to amino acids 88-352 of human SIRT6 (NP_057623) produced in E.coli.
0.1 mL
Primary
Human, Mouse, Rat
IgG1
Western Blot, Immunocytochemistry, Immunofluorescence
OTI1G3
Western Blot, Immunocytochemistry/Immunofluorescence
EC 3.5.1.-, NAD-dependent deacetylase sirtuin-6, SIR2L6sir2-related protein type 6, SIR2-like protein 6, sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae), sirtuin (silent mating type information regulation 2, S. cerevisiae, homolog) 6, sirtuin 6, sirtuin type 6
Mouse
Affinity Purified
Cancer, Chromatin Modifiers, Chromatin Research, DNA Repair, Epigenetics, Histone Deacetylases, Phospho Specific, Signal Transduction
51548.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.